OTC - ACTIVE INGREDIENT SECTION
Active ingredient Purpose
Salicylic Acid 0.5% Acne treatment tonic
Active ingredient Purpose
Salicylic Acid 0.5% Acne treatment tonic
Uses
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
When using this product
Using other topical acne medication at the same time or immediately following the use of this product may increase dryness of irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.
Warnings
For external use only
Directions
Inactive ingredients
Alcohol, Allantoin, Ammonium Acryloyldimethyltaurate/VP Copolymer, Bisabolol, Butylene Glycol, Butyrospermum Parkii (Shea) Butter, C12-15 Alkyl Benzoate, C13-14 Isoparaffin, Decylene Glycol, Dipropylene Glycol, Disodium EDTA, Ethylhexylglycerin, Glycerin, Honey Extract, Hydrogenated Lecithin, Lactobacillus Ferment, Laureth-7, Lecithin, Maltodextrin, Niacinamide, Panthenol, Phenethyl Alcohol, Phenoxyethanol, Polyacrylamide, Polyacrylate-13/Polyisobutene/Polysorbate-20, Royal Jelly Powder, Royal Jelly, Sodium Hydroxide, Sodium PCA,Spiraea Ulmaria Extract, Succinic Acid, Tetrapeptide-45, Water/Aqua, Zymomonas Ferment Extract
Jafra Royal
Clear Smart
Clear Pore Hydrator
50ml e 1.7 FL OZ (US)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68828-249-01 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-71f1-a426-e053-dadaa90af4c2 | Clear Smart Clear Pore Hydrator |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68828-249-01 | Clear Smart Clear Pore Hydrator | 50 mL in 1 BOTTLE | GEL | 50 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68828-249 | 68828-249-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a5787e12-2e46-cf75-e053-2a95a90a6e37 | a5787e12-2e45-cf75-e053-2a95a90a6e37 | 2020-05-12 | Warnings | a5787e12-2e46-cf75-e053-2a95a90a6e37 a5787e12-2e45-cf75-e053-2a95a90a6e37 |
Adverse event summaries are temporarily unavailable. Other product information remains available.